Comparison of Rosuvastatin Versus Atorvastatin in South-Asian Patients at Risk of Coronary Heart Disease (from the IRIS Trial)

American Journal of Cardiology

Volumn 99, Issue 11, 2007, Pages 1538-1543

  Deedwania, Prakash C ^a   Gupta, Milan ^b   Stein, Michael ^c   Yčas, Joseph ^c   Gold, Alex ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ATORVASTATIN; CREATINE KINASE; LOW DENSITY LIPOPROTEIN; ROSUVASTATIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; ASTHENIA; CHOLESTEROL BLOOD LEVEL; CONSTIPATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; HEMATURIA; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIORITY JOURNAL; PROTEINURIA; SHORT COURSE THERAPY; SOUTH ASIA; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEIN A-I; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CANADA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; FLUOROBENZENES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PYRIMIDINES; PYRROLES; RISK FACTORS; SULFONAMIDES; TREATMENT OUTCOME; UNITED STATES;

EID: 34248654864     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.01.028     Document Type: Article

References (15)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the Expert Panel on National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
2. Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., Kirby A., Sourjina T., Peto R., Collins R., Simes R., and Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
3. Maintenance and Support Services Organization (MSSO) of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) acting as trustee for the International Conference on Harmonisation (ICH) Steering Committee. Medical Dictionary for Regulatory Activities. Available at: http:www.meddramsso.com/mssoweb/index.htm. Accessed August 24, 2006.
4. Jones P.H., Davidson M.H., Stein E.A., Bays H.E., McKenney J.M., Miller E., Cain V.A., Blasetto J.W., and STELLAR Study Group. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial). Am J Cardiol 92 (2003) 152-160
5. Steiner P., Freidel J., Bremmer W., and Stein E. Standardization of micromethods for plasma cholesterol, triglyceride and HDL-cholesterol with the Lipid Research Clinics' methodology. [abstract]. J Clin Chem Biochem 19 (1981) 850-851
6. Miller Jr. R.G. Simultaneous Statistical Inference. 2nd Ed. (1981), Springer-Verlag, New York, New York
7. Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., Pasternak R.C., Smith Jr. S.C., Stone N.J., and Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
8. Deedwania P.C., and Gupta R. Prevention of coronary heart disease in Asian populations. In: Wong N.D. (Ed). Preventive Cardiology (2000), McGraw-Hill, New York, New York 503-516
9. Gupta M., Singh N., and Verma S. South Asians and cardiovascular risk: what clinicians should know. Circulation 113 (2006) e924-e929
10. Gupta M., and Brister S. Is South Asian ethnicity an independent cardiovascular risk factor?. Can J Cardiol 22 (2006) 193-197
11. US Census Bureau. Census 2000; search term "Asian." Available at: http://www.census.gov. Accessed August 24, 2006.
12. Statistics Canada, 2001. Search term "South Asian." Available at: http://www40.statcan.ca. Accessed August 24, 2006.
13. McPherson R., Frohlich J., Fodor G., and Genest J. Canadian Cardiovascular Society position statement-recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 22 (2006) 913-927
14. Ferdinand K.C., Clark L.T., Watson K.E., Neal R.C., Brown C.D., Kong B.W., Barnes B.O., Cox W.R., Zieve F.J., Isaacsohn J., et al., ARIES Study Group. Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial. Am J Cardiol 97 (2006) 229-235
15. Lloret R., Yčas J., Stein M., Haffner S., and STARSHIP Study Group. Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia from the STARSHIP trial. Am J Cardiol 98 (2006) 768-773